Vaccines for COVID‐19

Since the emergence of COVID‐19, caused by the SARS‐CoV‐2 virus at the end of 2019, there has been an explosion of vaccine development. By 24 September 2020, a staggering number of vaccines (more than 200) had started preclinical development, of which 43 had entered clinical trials, including some a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Immunol
Autors principals: Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.‐M., Pierce, B. F., Stirling, D. C., Wang, Z., Pollock, K. M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Article Collection: COVID‐19
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7597597/
https://ncbi.nlm.nih.gov/pubmed/32935331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13517
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars